GOVERNMENT CONTRACT / DELIVERY ORDER
NHLBI'S DIVISION OF CARDIOVASCULAR SCIENCES (DCVS) PROGRAM IN PREVENTION AND POPULATION SCIENCES (PPPS) REQUIRES A RENEWAL FOR CONTRACT SERVICES FOR A THE PART-TIME CONTRACTOR POSI
Awarded to ASTRIX TECHNOLOGY LLC
- Company legal name
- ASTRIX TECHNOLOGY LLC
- UEI / CAGE
- NRVNN8E6NCK4 / Not reported
- Parent award
- Not reported
- Awarding agency
- Department of Health and Human Services
- Subagency
- National Institutes of Health
- Industry
- Not reported
- NAICS
- 541712
- PSC
- R499
- Performance period
- Not reported — Not reported
- Recipient address
- 125 HALF MILE RD STE 200, RED BANK, MONMOUTH, NJ, 07701
- Place of performance
- BETHESDA, MONTGOMERY, MD, 20892
- Source last modified
- Oct 21, 2026
Description
NHLBI'S DIVISION OF CARDIOVASCULAR SCIENCES (DCVS) PROGRAM IN PREVENTION AND POPULATION SCIENCES (PPPS) REQUIRES A RENEWAL FOR CONTRACT SERVICES FOR A THE PART-TIME CONTRACTOR POSITION A AN ADVISOR FOR A TOTAL OF 520 HOURS FOR A ONE YEAR PERFORMANCE PERIOD FROM APRIL 1, 2019-MARCH 31, 2020. IN ORDER TO DEVELOP AND CONDUCT EVALUATIONS OF LARGE CLINICAL TRIALS AND COHORT STUDIES, ACTIVE PARTICIPATION WITH DCVS STAFF IN DEVELOPING NEW WORKSHOPS AND INITIATIVE.
Derived from official transactions
Contract lifecycle
- Award announced
NHLBI'S DIVISION OF CARDIOVASCULAR SCIENCES (DCVS) PROGRAM IN PREVENTION AND POPULATION SCIENCES (PPPS) REQUIRES A RENEWAL FOR CONTRACT SERVICES FOR A THE PART-TIME CONTRACTOR POSI
Point-in-time model
Contract change outlook
Uncollapsed source history
Transactions and modifications
| Action date | Modification | Action type | Exact obligation | Current total | Potential total | Description | Source |
|---|---|---|---|---|---|---|---|
| Mar 20, 2019 | 0 | Not reported | $54,756.00 | Not reported | Not reported | NHLBI'S DIVISION OF CARDIOVASCULAR SCIENCES (DCVS) PROGRAM IN PREVENTION AND POPULATION SCIENCES (PPPS) REQUIRES A RENEWAL FOR CONTRACT SERVICES FOR A THE PART-TIME CONTRACTOR POSITION A AN ADVISOR FOR A TOTAL OF 520 HOURS FOR A ONE YEAR PERFORMANCE PERIOD FROM APRIL 1, 2019-MARCH 31, 2020. IN ORDER TO DEVELOP AND CONDUCT EVALUATIONS OF LARGE CLINICAL TRIALS AND COHORT STUDIES, ACTIVE PARTICIPATION WITH DCVS STAFF IN DEVELOPING NEW WORKSHOPS AND INITIATIVE. | USAspending ↗ |